Mesoblast (MESO) had the highest return in March 2024 by a mid-cap US stock, returning 151.8%.

ASSET	MONTH	% RETURN
Mesoblast (MESO)	March 2024	151.76%
Apogee Therapeutics, Inc Common Stock (APGE)	March 2024	90.67%
Sezzle (SEZL)	March 2024	87.71%
WM Technology (MAPSW)	March 2024	85.19%
Cipher Mining (CIFR)	March 2024	71.67%
Nuscale Power (SMR)	March 2024	70.19%
Trump Media & Technology (DJTWW)	March 2024	68.51%
Endeavour Silver (EXK)	March 2024	62.84%
Trump Media & Technology (DJT)	March 2024	61.02%
Advantage Solutions (ADVWW)	March 2024	52.94%
Nextnav Acquisition (NN)	March 2024	52.67%
CompoSecure (CMPO)	March 2024	48.15%
Equinox Gold (EQX)	March 2024	46.83%
Paymentus (PAY)	March 2024	45.74%
Gap (GAP)	March 2024	45%
Century Aluminum (CENX)	March 2024	44.51%
Perpetua Resources (PPTA)	March 2024	40.54%
Dave (DAVE)	March 2024	40.1%
Celcuity LLC (CELC)	March 2024	39.72%
Terawulf (WULF)	March 2024	38.42%
Avidity Biosciences (RNA)	March 2024	38.17%
Fortuna Silver Mines (FSM)	March 2024	36.13%
Atmus Filtration Technologies (ATMU)	March 2024	35.11%
Hecla Mining (HL)	March 2024	34.56%
Eldorado Gold (EGO)	March 2024	33.36%

Mid-cap stocks are treated as having a market cap between $2B and $10B.